Tesofensine (250mcg) / Dihexa (5mg) × 60 Tablets

This dual-compound formulation combines Tesofensine and Dihexa — two research molecules studied for their complementary effects on metabolic regulation and cognitive function. Designed for investigators exploring central nervous system signaling, neurotrophic activity, and energy metabolism, this blend provides a versatile tool for studying the interaction between metabolic modulation and neuroplasticity pathways.

Blend Composition (Per Tablet):
Tesofensine – 250mcg
Dihexa – 5mg
60 tablets per bottle

Key Characteristics:

• Tesofensine: Monoamine reuptake inhibitor investigated for its effects on appetite regulation, energy expenditure, and central metabolic activity

• Dihexa: Angiotensin IV analogue studied for promoting synaptic growth and cognitive enhancement in preclinical research

• Oral delivery format designed for compound stability and consistent dosing

• Balanced formulation supporting dual-focus research in metabolic and neurological domains

Intended Use:
This product is intended for laboratory research use only. It is not for human consumption, therapeutic use, or diagnostic purposes. Any application outside of approved research protocols is strictly prohibited.